Format

Send to

Choose Destination
J Clin Microbiol. 2014 Jul;52(7):2650-2. doi: 10.1128/JCM.00132-14. Epub 2014 Apr 30.

Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis C outbreak investigation.

Author information

1
Public Health Laboratories, Division of Public Health Services, New Hampshire Department of Health and Human Services, Concord, New Hampshire, USA.
2
Division of Public Health Services, New Hampshire Department of Health and Human Services, Concord, New Hampshire, USA Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
3
Division of Public Health Services, New Hampshire Department of Health and Human Services, Concord, New Hampshire, USA.
4
Public Health Laboratories, Division of Public Health Services, New Hampshire Department of Health and Human Services, Concord, New Hampshire, USA clbean@dhhs.state.nh.us.

Abstract

During a nosocomial hepatitis C outbreak, emergency public clinics employed the OraQuick HCV rapid antibody test on site, and all results were verified by a standard enzyme immunoassay (EIA). Of 1,157 persons, 1,149 (99.3%) exhibited concordant results between the two tests (16 positive, 1,133 negative). The sensitivity, specificity, positive predictive value, and negative predictive value were 94.1%, 99.5%, 72.7%, and 99.9%, respectively. OraQuick performed well as a screening test during an outbreak investigation and could be integrated into future hepatitis C virus (HCV) outbreak testing algorithms.

PMID:
24789176
PMCID:
PMC4097725
DOI:
10.1128/JCM.00132-14
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center